Given these beneficial effects of oxytocin administration on factors associated with increased PTSD risk, it was hypothesized that administration of intranasal oxytocin early posttrauma may prevent subsequent PTSD symptom development (Olff, 2012). The gene discussed is OXT; the disease is post-traumatic stress disorder.